2014
Pacific Edge Launches Cxbladder Triage
Dunedin-based Pacific Edge has released today the second product in its suite of diagnostic tests for the detection and management of bladder cancer. [read more]
2015 Half Year Conference Call
Conference call audio commentary available here [read more]
Pacific Edge Reports Commercial Progress and Revenue Growth
Interim Results Announcement for the six months to 30 September 2014 [read more]
Europe Grants Pacific Edge Patent For Colorectal Cancer Prognostic Technology
The European Intellectual Property Office which operates across 38 countries including all European Union members, has awarded Pacific Edge a patent for its colorectal cancer prognostic technology. [read more]
Interim Results To Be Released 28 November 2014
Pacific Edge advises that it intends to release its 2015 interim financial results for the six months ending 30 September 2014, on Friday 28 November 2014 prior to 10am. [read more]
Pacific Edge announces appointment of Chief Financial Officer
Pacific Edge is pleased to announce the appointment of Kate Rankin as Chief Financial Officer with effect from 17 November 2014. [read more]
Japan grants Pacific Edge patent for colorectal cancer prognostic technology
The world's second largest single biomedical market, Japan, has awarded Pacific Edge a patent for its colorectal cancer prognostic technology. [read more]
Pacific Edge appoints Charles Sitch as an Independent Director
Pacific Edge is pleased to announce the appointment of Charles Sitch as an Independent Director. [read more]
US grants Pacific Edge patent for melanoma detection
The United States Patent Office has granted Pacific Edge patent protection for 'Prognosis Prediction for Melanoma'. [read more]
Cxbladder User Program research agreement signed with Kaiser Permanente Southern California
Pacific Edge Ltd hassigned an agreement with Southern California Permanente Medical Group (SCPMG) to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente's health care network. [read more]
Pacific Edge building its presence in world's largest biomedical market
At its annual shareholders' meeting held yesterday in Dunedin, New Zealand, cancer diagnostic developer, Pacific Edge, celebrated the commercial launch of its flagship bladder cancer diagnostic product, Cxbladder, into the US and provided shareholders with an update on its growth plans. [read more]
Pacific Edge refreshes board of directors
Cancer diagnostic specialist, Pacific Edge, is looking to add further commercial and international expertise to its Board as it builds its sales and marketing platform in the United States and looks to expand its footprint in other markets. [read more]
Pacific Edge AGM Announcement
The 2014 annual meeting of shareholders of Pacific Edge Limited ("ìthe Company") will be held at the Dunedin Public Art Gallery, Otago Daily Times Gallery. [read more]
Cxbladder testing service e-commerce site goes live in New Zealand
All New Zealand residents and healthcare professionals can today access the Cxbladder cancer detection technology developed by Dunedin-based Pacific Edge with the "go live" of an e-commerce platform. [read more]
Pacific Edge to launch New Zealand e-commerce site for bladder cancer testing service
Cancer diagnostic developer and service provider Pacific Edge is set to launch an e-commerce platform later this month to make its Cxbladder technology available to all New Zealanders from the convenience of their home. [read more]
Pacific Edge Annual Report 2014
Please click link to download Pacific Edge's 2014 Annual Report [read more]
Pacific Edge Attends GPCME Conference
Pacific Edge Diagnostics NZ will be exhibiting the Cxbladder bladder cancer detection tests at the 2014 GP CME in Rotorua this weekend. [read more]
Attending the MTANZ 2014 Healthcare Congress
Are you attending the MTANZ 2014 Healthcare Congress in Auckland on Monday? If so, the Pacific Edge team will see you there! [read more]
Pacific Edge signs Cxbladder agreement with MultiPlan
Pacific Edge announced today that it has entered into a contractual agreement with MultiPlan, Inc. for diagnostics laboratory testing. [read more]
Pacific Edge named Top Bioscience Company in 2014
Pacific Edge has been named NZBIO’s top bioscience company for 2014. Pacific Edge was specifically recognised for building the profile and credibility of biotechnology and biotechnology companies in New Zealand. [read more]
Calling All Interns
Pacific Edge Limited has successfully employed undergraduate and graduate interns into its science and marketing programs for several years. [read more]
Technology Upgrades Underway
Pacific Edge Limited has recently invested in the latest top of the range measurement equipment to improve the accuracy and precision of its diagnostic test. [read more]
Meet the Team
Each newsletter we will introduce you to one of our staff members so that you can get to know the team. This edition is Carthika Luxmanan, a Scientist at Pacific Edge. [read more]
Exporter Magazine Profile: A long, hard road to success
Pacific Edge is a Dunedin cancer diagnostics company chasing a huge global opportunity with its novel gene test for the detection and management of bladder cancer. [read more]
Callaghan Innovation Growth Grant accelerates Cxbladder development
Pacific Edge is delighted to have the support of Callaghan Innovation to further accelerate the development of its molecular cancer detection technology. [read more]
BOP and Lakes Urologists adopt Cxbladder
Patients presenting with symptoms of bladder cancer and those under surveillance of bladder cancer in the Bay of Plenty and Lakes District Health Board regions will now be evaluated as part of their clinical program, with Pacific Edge's non-invasive urine sampling Cxbladder Detect test. [read more]
Health Innovation Hub signs commercial agreement
Health Innovation Hub signs commercial agreement for entry of Cxbladder to DHBs [read more]
Cxbladder Boosting Confidence in Bladder Cancer Detection in the US
New, urine based test offers patients greater peace of mind from accurate, reliable results. [read more]
View our Calendar of Events
We welcome press and media enquiries. For further assistance, please feel free to contact us.